DLL4 and metastatic colorectal cancer: Other examples use either a bispecific DLL4/VEGF antibody (OMP-305B83) in metastatic colorectal cancer, combined with the chemotherapeutic agents FOLFIRI (NCT03035253); or in combination with the chemotherapeutics carboplatin and pemetrexed for lung cancer (NCT01189968).